Axar.az
UP

Axar.Az Logo

Pfizer vaccine 'works' against key variant mutation

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The Pfizer/BioNTech vaccine can still target a key mutation that has emerged in two new variants of coronavirus, laboratory studies show.

Axar.az reports that however, this is only one of many mutations that are found in the new forms of the virus.

So while the study has been welcomed, it is not being seen as definitive scientific evidence about how the vaccine will perform.

New variants have been detected in the UK and South Africa.

Both forms of the virus are spreading more quickly and this has raised questions over what level of protection vaccines can offer against them.

The widely held view is that vaccines will still work, but researchers are on the hunt for proof.

Date
2021.01.08 / 19:31
Author
Axar.az
Comments
See also

WHO doesn’t recommend introducing Covid passports for now

Senegal receives 324,000 doses of AstraZeneca vaccine

There is no East and West vaccine, there is good and bad

WHO to allocate 227M COVAX shots by end of May

Russia’s Sputnik V vaccine registered in Slovakia

US regulator approves Johnson&Johnson coronavirus vaccine

WHO reports over 420,000 new daily cases of COVID-19

Global COVID-19 deaths surpass 2.5 mln

Johnson & Johnson's one-dose vaccine closes in on U.S. approval

World's first doses of Covax vaccines delivered

Latest
 
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla